---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-23-007031"
form_type: "8-K"
ticker: "COSM"
cik: "0001474167"
company_name: "Cosmos Health Inc."
filed_at: "2023-09-22T23:59:59+00:00"
generated_at: "2026-06-10T09:38:26.891920+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Cosmos Health CCO resigns; shareholders approve reverse split authorization and equity plan

## Summary
- Chief Communications Officer Pavlos Ignatiades resigned effective Sept 20, 2023.
- Shareholders elected all six director nominees with over 94% affirmative votes each.
- Ratified October 2022 public offering (97.77% for) and approved 2023 equity incentive plan (94.19% for).
- Board authorized to effect reverse stock split at its discretion; 97.67% of votes in favor.

## SEC filing metadata
- accession: 0001477932-23-007031
- form_type: 8-K
- ticker: COSM
- cik: 0001474167
- company_name: Cosmos Health Inc.
- filed_at: 2023-09-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1474167/000147793223007031/0001477932-23-007031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1474167/000147793223007031/cosm_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-23-007031
- JSON: https://secwatch.observer/filing/0001477932-23-007031.json
- Plain text: https://secwatch.observer/filing/0001477932-23-007031.txt

## Key facts
- Executive change
  Pavlos Ignatiades resigned as Chief Communications Officer at Cosmos Health Inc..
  - Action: resigned
  - Role: Chief Communications Officer
  source text: On September 20, 2023, Pavlos Ignatiades, our Chief Communications Officer, resigned effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1474167/000147793223007031/0001477932-23-007031-index.htm
- Shareholder Votes
  Cosmos Health Inc. shareholders approved To ratify the October 2022 Public Offering at the 2023-09-18 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-09-18
  source text: 2. To ratify the October 2022 Public Offering: For Against Abstain % Votes Affirmative 4,770,999 106,633 2,070 97.77 %
  evidence_url: https://www.sec.gov/Archives/edgar/data/1474167/000147793223007031/0001477932-23-007031-index.htm
- Shareholder Votes
  Cosmos Health Inc. shareholders approved To authorize the Board of Directors to amend the Articles of Incorporation to effect a reverse stock split of the Company's outstanding common stock at their discretion at the 2023-09-18 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2023-09-18
  source text: 4. To authorize the Board of Directors to amend the Articles of Incorporation to effect a reverse stock split of the Company’s outstanding common stock at their discretion: For Against Abstain % Votes Affirmative 4,766,157 113,059 486 97.67 %
  evidence_url: https://www.sec.gov/Archives/edgar/data/1474167/000147793223007031/0001477932-23-007031-index.htm
- Shareholder Votes
  Cosmos Health Inc. shareholders approved Election of Directors at the 2023-09-18 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-09-18
  source text: 1. Election of Directors: Nomination For Withheld % Votes Affirmative 01 - Grigorios Siokas 4,606,832 272,870 94.41 % 02 - Demetrios G. Demetriades 4,867,713 11,989 99.75 % 03 - John J. Hoidas 4,872,529 7,173 99.85 % 04 - Dr. Anastasios Aslidis 4,808,836 70,866 98.55 % 05 - Dr. Manfred Ziegler 4,829,695 50,007 98.98 % 06 - Suhel Bhutawala 4,829,523 50,179 98.97 %
  evidence_url: https://www.sec.gov/Archives/edgar/data/1474167/000147793223007031/0001477932-23-007031-index.htm
- Shareholder Votes
  Cosmos Health Inc. shareholders approved To approve the Company's 2023 equity incentive plan at the 2023-09-18 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-09-18
  source text: 3. To approve the Company’s 2023 equity incentive plan: For Against Abstain % Votes Affirmative 4,596,072 277,077 6,553 94.19 %
  evidence_url: https://www.sec.gov/Archives/edgar/data/1474167/000147793223007031/0001477932-23-007031-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.